Slingshot members are tracking this event:

Phase 1 biomarker data of Sage Therapeutics' (SAGE) SAGE-718 in Huntington's disease due July 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
SAGE Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sage-718, Huntington's Disease, Biomarker Data